Two hypotheses were proposed to explain ERα association with breast cancer: (i) products of estrogen metabolism are genotoxic causing an increased risk of direct DNA damage; (ii) estrogen-induced activity of estrogen receptors stimulates proliferation leading to increased risk of DNA mutations due to high rates of DNA replication. This evidence concerns the gene ESR1 and breast carcinoma.